If you live with PMDD and also suspect or know you have ADHD, this large international review offers important insights into why these two conditions may be connected — and why your premenstrual symptoms might feel especially intense.
A group of 42 researchers from across Europe and beyond examined what is known about ADHD in girls and women throughout their lives. A key finding: two-thirds of women with ADHD surveyed reported experiencing PMS and/or PMDD, with 80% reporting premenstrual irritability, 79% mood swings, and 66% trouble concentrating. Research also shows that ADHD is more commonly found in women who have PMDD. The proposed explanation centers on how the hormone oestrogen supports dopamine — a brain chemical already lower or less regulated in people with ADHD. When oestrogen drops before your period, during postpartum, or in perimenopause, the effect on dopamine may hit women with ADHD harder, worsening both mood and focus.
The review also highlights that women with ADHD face a 5–6 times higher risk of postpartum depression, and during perimenopause, 70% described ADHD as having a "life-altering" impact. The authors argue that these hormonal transitions deserve much more research attention, including looking at whether adjusting ADHD medication doses across the menstrual cycle or adding treatments like SSRIs or hormonal therapy could help.
While this paper does not provide new clinical data, it brings together the strongest case yet for why hormonal changes and ADHD — including PMDD — need to be studied together. If you feel your PMDD symptoms are intertwined with attention and focus difficulties, you are not imagining it, and researchers are increasingly calling for better answers and treatments.
Key findings
- Two-thirds of women with ADHD reported experiencing PMS and/or PMDD, with premenstrual symptoms including irritability (80%), mood swings (79%), tension/anxiety (68%), and lack of focus/concentration (66%)
- Premenstrual depressive symptoms were significantly higher in women with clinically diagnosed ADHD than in the general population (45% vs. 28%), and postpartum depression symptoms were three times more prevalent (58% vs. 19%)
- Perimenopausal complaints in women with ADHD showed a large effect size (Cohen's d = 3.71) compared to the general population
- Combined oral contraceptives and progestin-only pills increased the risk of depression up to five times in women with ADHD compared to unaffected women
- ADHD prevalence has been shown to be increased in women with PMDD, and women with ADHD have increased vulnerability to PMDD
- 70% of women with ADHD reported the condition had a 'life-altering' impact during their 40s and 50s (perimenopause), with 50% calling their ADHD 'extremely severe'
Methods, briefly
Position paper and narrative review by the Eunethydis Special Interest Group on Female ADHD (42 researchers). Synthesised existing literature and self-reported experiences of women with ADHD. Incorporated survey data from ADDitude (750 women and a separate survey of 4,000 women with ADHD) and Duke Center (1,350 women). No systematic search protocol described.
Limitations to keep in mind
- Narrative review without systematic search methodology, increasing risk of selection bias in cited literature
- Much of the cited evidence on hormonal effects in ADHD relies on self-report surveys from advocacy platforms rather than controlled clinical studies
- Most existing research focuses on cisgender women, limiting generalisability to transgender and non-binary individuals
- Many of the hormonal-ADHD interaction mechanisms discussed are proposed rather than established, with preliminary or indirect evidence
- Survey respondents from ADDitude and Duke Center were mostly self-reported ADHD, not all clinically diagnosed
The latest PMDD research, in your pocket
The app’s research feed is updated daily with newly published, peer-reviewed PMDD work - summarized in plain language.